Last reviewed · How we verify
NCT05542030
CAD EYE Detection of Remaining Lesions After EMR
NA trial testing EMR with CAD-Eye™ in Colorectal Dysplasia in 60 participants. Status unknown.
1 March 2024
Quick facts
| Lead sponsor | Instituto Ecuatoriano de Enfermedades Digestivas |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 60 |
| Start date | 12 September 2022 |
| Primary completion | 1 March 2024 |
| Estimated completion | 12 September 2024 |
| Sites | 1 location across Ecuador |
Drugs / interventions tested
- EMR with CAD-Eye™
- EMR without CAD-Eye™
- Follow-up colonoscopy with CAD-Eye™
Conditions studied
- Colorectal Dysplasia — all drugs for Colorectal Dysplasia →
- Colorectal Neoplasms — all drugs for Colorectal Neoplasms →
Sponsor
Instituto Ecuatoriano de Enfermedades Digestivas — full company profile →
Who can join
Adults 18 to 90, any sex, with Colorectal Dysplasia or Colorectal Neoplasms. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In the last decade, many innovative systems have been developed to support and improve the diagnosis accuracy during endoscopic studies. CAD-Eye™ (Fujifilm, Tokyo, Japan) is a computer-assisted diagnostic (CADx) system that uses artificial intelligence for the detection and characterization of polyps during colonoscopy. However, the accuracy of CAD-Eye™ in the recognition of remaining lesions after endoscopic mucosal resection (EMR) has not been broadly evaluated. Finally, based on the importance of complete resection of the colonic mucosal lesions, namely suspicious high-grade dysplasia or early invasive cancer, the investigators aimed to assess the accuracy of CAD-Eye™ in the detection of remaining lesions after the procedure.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05542030
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Colorectal Dysplasia
Currently open trials in the same condition.
- NCT06342440 — Early Detection of Advanced Adenomas and Colorectal Cancer · recruiting
Other Instituto Ecuatoriano de Enfermedades Digestivas trials
Trials by the same sponsor.
- NCT05453292 — Endoscopic Ultrasound Radiofrequency Ablation for GISTs · NA · unknown
- NCT06298604 — Motorized Fine Needle Biopsy vs Standard Needles · NA · unknown
- NCT06264466 — Safety and Efficacy of a Novel Flexible Bipolar in POEM · NA · unknown
- NCT06102980 — Endoscopic Ultrasound Shear Wave for Liver Fibrosis in MASLD Patients: The RUMIPAMBA Trial · NA · recruiting
- NCT06038201 — Cholecystectomy vs EUS-guided GBD With Stone Removal · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05542030 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Instituto Ecuatoriano de Enfermedades Digestivas
- Last refreshed: 28 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05542030.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing